Cardenas H - Search Results

1

In vivo tumor growth of high-grade serous ovarian cancer cell lines.

Mitra AK, Davis DA, Tomar S, Roy L, Gurler H, Xie J, Lantvit DD, Cardenas H, Fang F, Liu Y, Loughran E, Yang J, Sharon Stack M, Emerson RE, Cowden Dahl KD, V Barbolina M, Nephew KP, Matei D, Burdette JE. Mitra AK, et al. Among authors: cardenas h. Gynecol Oncol. 2015 Aug;138(2):372-7. doi: 10.1016/j.ygyno.2015.05.040. Epub 2015 Jun 5. Gynecol Oncol. 2015. PMID: 26050922 Free PMC article.

2

Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer.

de Leon M, Cardenas H, Vieth E, Emerson R, Segar M, Liu Y, Nephew K, Matei D. de Leon M, et al. Among authors: cardenas h. Gynecol Oncol. 2016 Sep;142(3):539-47. doi: 10.1016/j.ygyno.2016.06.017. Epub 2016 Jun 30. Gynecol Oncol. 2016. PMID: 27374141 Free PMC article.

3

Methylomic Signatures of High Grade Serous Ovarian Cancer.

Cardenas H, Fang F, Jiang G, Perkins SM, Zhang C, Emerson RE, Hutchins G, Keer HN, Liu Y, Matei D, Nephew K. Cardenas H, et al. Epigenetics. 2021 Nov;16(11):1201-1216. doi: 10.1080/15592294.2020.1853402. Epub 2020 Dec 8. Epigenetics. 2021. PMID: 33289590 Free PMC article.

4

Epigenetic targeting of ovarian cancer stem cells.

Wang Y, Cardenas H, Fang F, Condello S, Taverna P, Segar M, Liu Y, Nephew KP, Matei D. Wang Y, et al. Among authors: cardenas h. Cancer Res. 2014 Sep 1;74(17):4922-36. doi: 10.1158/0008-5472.CAN-14-1022. Epub 2014 Jul 17. Cancer Res. 2014. PMID: 25035395 Free PMC article.

5

EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.

Cardenas H, Zhao J, Vieth E, Nephew KP, Matei D. Cardenas H, et al. Oncotarget. 2016 Dec 20;7(51):84453-84467. doi: 10.18632/oncotarget.11497. Oncotarget. 2016. PMID: 27563817 Free PMC article.

6

Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs.

Fang F, Cardenas H, Huang H, Jiang G, Perkins SM, Zhang C, Keer HN, Liu Y, Nephew KP, Matei D. Fang F, et al. Among authors: cardenas h. Cancer Res. 2018 Feb 1;78(3):631-644. doi: 10.1158/0008-5472.CAN-17-1492. Epub 2017 Dec 11. Cancer Res. 2018. PMID: 29229600 Free PMC article.

7

Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer.

Cardenas H, Jiang G, Thomes Pepin J, Parker JB, Condello S, Nephew KP, Nakshatri H, Chakravarti D, Liu Y, Matei D. Cardenas H, et al. NPJ Precis Oncol. 2019 Dec 6;3:32. doi: 10.1038/s41698-019-0103-4. eCollection 2019. NPJ Precis Oncol. 2019. PMID: 31840082 Free PMC article.

8

TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.

Cardenas H, Vieth E, Lee J, Segar M, Liu Y, Nephew KP, Matei D. Cardenas H, et al. Epigenetics. 2014 Nov;9(11):1461-72. doi: 10.4161/15592294.2014.971608. Epigenetics. 2014. PMID: 25470663 Free PMC article.

9

Ovarian Cancer-Why Lipids Matter.

Zhao G, Cardenas H, Matei D. Zhao G, et al. Among authors: cardenas h. Cancers (Basel). 2019 Nov 26;11(12):1870. doi: 10.3390/cancers11121870. Cancers (Basel). 2019. PMID: 31769430 Free PMC article. Review.

10

Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer.

Sima LE, Chen S, Cardenas H, Zhao G, Wang Y, Ivan C, Huang H, Zhang B, Matei D. Sima LE, et al. Among authors: cardenas h. J Immunother Cancer. 2021 Sep;9(9):e002682. doi: 10.1136/jitc-2021-002682. J Immunother Cancer. 2021. PMID: 34593619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters